312 related articles for article (PubMed ID: 17013903)
1. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
[No Abstract] [Full Text] [Related]
2. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
3. Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.
Bacorro EA; Tehrani R
J Clin Rheumatol; 2010 Aug; 16(5):237-9. PubMed ID: 20577094
[TBL] [Abstract][Full Text] [Related]
4. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.
Gordon CR; Zivotofsky AZ; Siman-Tov T; Gadoth N
Neurology; 2007 Apr; 68(14):1161; author reply 1161. PubMed ID: 17404205
[No Abstract] [Full Text] [Related]
5. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
8. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
[No Abstract] [Full Text] [Related]
9. High-dose intravenous immune globulin for stiff-person syndrome.
Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B
N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase antibody-positive paraneoplastic stiff limb syndrome associated with carcinoma of the breast.
Agarwal PA; Ichaporia NR
Neurol India; 2010; 58(3):449-51. PubMed ID: 20644278
[TBL] [Abstract][Full Text] [Related]
12. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series.
Fernandes M; Munhoz RP; Carrilho PE; Arruda WO; Lorenzoni PJ; Scola RH; Werneck LC; Teive HA
Arq Neuropsiquiatr; 2012 Sep; 70(9):657-61. PubMed ID: 22990719
[TBL] [Abstract][Full Text] [Related]
13. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
14. Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies.
Ances BM; Dalmau JO; Tsai J; Hasbani MJ; Galetta SL
Am J Ophthalmol; 2005 Jul; 140(1):142-4. PubMed ID: 16038662
[TBL] [Abstract][Full Text] [Related]
15. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
16. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
Ferraz HB
Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
[No Abstract] [Full Text] [Related]
17. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
Jarius S; Stich O; Speck J; Rasiah Ch; Wildemann B; Meinck HM; Rauer S
J Neuroimmunol; 2010 Dec; 229(1-2):219-24. PubMed ID: 20813415
[TBL] [Abstract][Full Text] [Related]
18. Stiff-person syndrome following West Nile fever.
Hassin-Baer S; Kirson ED; Shulman L; Buchman AS; Bin H; Hindiyeh M; Markevich L; Mendelson E
Arch Neurol; 2004 Jun; 61(6):938-41. PubMed ID: 15210535
[TBL] [Abstract][Full Text] [Related]
19. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
20. Excellent response to steroid treatment in anti-GAD cerebellar ataxia.
Lauria G; Pareyson D; Pitzolu MG; Bazzigaluppi E
Lancet Neurol; 2003 Oct; 2(10):634-5. PubMed ID: 14505586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
